Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

321
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
321
Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

61
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
61
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis.

HemaSphere·2026
Same author

An oncogenic KRAS-driven secretome involving TNFα promotes niche preparation prior to pancreatic cancer onset.

Molecular cancer·2026
Same author

PHLOWER leverages single-cell multimodal data to infer complex, multi-branching cell differentiation trajectories.

Nature methods·2025
Same author

PILOT-GM-VAE: patient-level analysis of single-cell disease atlas with optimal transport of Gaussian mixture variational autoencoders.

Briefings in bioinformatics·2025
Same author

Inhibiting the alarmin-driven hematopoiesis-stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis.

HemaSphere·2025
Same author

Advances and challenges in cell-cell communication inference: a comprehensive review of tools, resources, and future directions.

Briefings in bioinformatics·2025
Same journal

Covariance decomposition for distance based species tree estimation.

BMC bioinformatics·2026
Same journal

SNPio: a Python interface for population genomic data processing.

BMC bioinformatics·2026
Same journal

SpaHNR: a spatial domain identification method via sparse attention-based hierarchical node representation and multi-view contrastive learning.

BMC bioinformatics·2026
Same journal

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026
Same journal

NAP: an open source pipeline for cross-domain microbiome profiling using Nanopore sequencing-derived amplicon data.

BMC bioinformatics·2026
Same journal

SurvGME: an R package for survival analysis with graphical and measurement error models.

BMC bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

A multiple kernel learning algorithm for drug-target interaction prediction.

André C A Nascimento1,2,3, Ricardo B C Prudêncio4, Ivan G Costa5,6,7

  • 1Center of Informatics, UFPE, Recife, Brazil. acan@cin.ufpe.br.

BMC Bioinformatics
|January 24, 2016
PubMed
Summary
This summary is machine-generated.

KronRLS-MKL enhances drug-target interaction prediction by integrating multiple data sources and handling large networks. This method effectively identifies relevant biological information, improving drug discovery efficiency.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K

Related Experiment Videos

Last Updated: Mar 26, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Pharmacology

Background:

  • Drug-target networks are crucial for pharmaceutical innovation and drug lead discovery.
  • Existing in silico methods, often kernel-based, struggle with large interaction spaces and integrating diverse biological data.
  • There is a need for advanced computational approaches to identify novel drug-target interactions efficiently.

Purpose of the Study:

  • To introduce KronRLS-MKL, a novel method for predicting drug-target interactions.
  • To enable the integration of multiple heterogeneous biological information sources.
  • To develop a scalable method capable of handling large drug-target interaction networks.

Main Methods:

  • Modeled drug-target interaction as a link prediction task on bipartite networks.
  • Utilized KronRLS-MKL to integrate multiple heterogeneous data sources.
  • Implemented automatic kernel selection with weights indicating feature importance.

Main Results:

  • KronRLS-MKL demonstrated superior or comparable predictive performance against 18 competing methods across four datasets.
  • The method successfully integrated multiple information sources, improving prediction quality.
  • Automatically selected kernels reflected their predictive relevance, highlighting successful biological source identification.

Conclusions:

  • The proposed data integration strategy significantly enhances the quality of predicted drug-target interactions.
  • KronRLS-MKL accelerates the identification of new drug-target interactions.
  • The method successfully identifies and leverages relevant biological information for improved drug discovery.